In-vivo evaluation of an in situ polymer precipitation delivery system for a novel natriuretic peptide.

by Soo Ghim Lim, Subbu S Venkatraman, John C Burnett, Horng H Chen
Published 2013-01-01

Incidence of Preclinical Heart Failure in a Community Population

by Kathleen A. Young, Christopher G. Scott, Richard J. Rodeheffer, Horng H. Chen
Published 2022-08-01

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study

by Siu-Hin Wan, MD, Joshua P. Slusser, BS, David O. Hodge, MS, Horng H. Chen, MBBCh
Published 2018-06-01

Cenderitide-eluting film for potential cardiac patch applications.

by Xu Wen Ng, Yingying Huang, Horng H Chen, John C Burnett, Freddy Y C Boey, Subbu S Venkatraman
Published 2013-01-01

Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes

by Fadi W. Adel, Ye Zheng, Siu-Hin Wan, Christie Greason, Shuchong Pan, Syed Ameenuddin, Horng H. Chen
Published 2022-04-01

Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure

by Scott A. Hubers, Siu‐Hin Wan, Fadi W. Adel, Sherry L. Benike, John C. Burnett, Christopher Scott, Horng H. Chen
Published 2022-01-01

Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction

by Siu‐Hin Wan, Paul M. McKie, Joshua P. Slusser, John C. Burnett Jr, David O. Hodge, Horng H. Chen
Published 2021-08-01

Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.

by Shuchong Pan, Horng H Chen, Cristina Correia, Haiming Dai, Tyra A Witt, Laurel S Kleppe, John C Burnett, Robert D Simari
Published 2014-01-01

CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.

by Fernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, Paul M McKie, Tomoko Ichiki, Horng H Chen, Josef Korinek, Gerald E Harders, John C Burnett
Published 2012-01-01

Soluble ST2 in Heart Failure With Preserved Ejection Fraction

by Omar F. AbouEzzeddine, Paul M. McKie, Shannon M. Dunlay, Susanna R. Stevens, G. Michael Felker, Barry A. Borlaug, Horng H. Chen, Russell P. Tracy, Eugene Braunwald, Margaret M. Redfield
Published 2017-02-01

Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation

by Xiao Ma, Seethalakshmi R. Iyer, Xiaoyu Ma, Shawn H. Reginauld, Yang Chen, Shuchong Pan, Ye Zheng, Dante G. Moroni, Yue Yu, Lianwen Zhang, Valentina Cannone, Horng H. Chen, Carlos M. Ferrario, S. Jeson Sangaralingham, John C. Burnett
Published 2023-05-01

Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP

by Siu-Hin Wan, MD, Isabel Torres-Courchoud, MD, PhD, Paul M. McKie, MD, Joshua P. Slusser, BSc, Margaret M. Redfield, MD, John C. Burnett, Jr., MD, David O. Hodge, MS, Horng H. Chen, MBBCh
Published 2019-12-01

Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis

by Marat Fudim, Nicolas Ashur, Aaron D. Jones, Andrew P. Ambrosy, Bradley A. Bart, Javed Butler, Horng H. Chen, Stephen J. Greene, Yogesh Reddy, Margaret M. Redfield, Abhinav Sharma, Adrian F. Hernandez, Gary Michael Felker, Barry A. Borlaug, Robert J. Mentz
Published 2021-02-01